Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Hyperglycaemia in the acute care setting

Derek Bell, Anjali Balasanthiran, Ben Zalin, Emma H Baker and Kevin Shotliff
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.12-3-272
Clin Med June 2012
Derek Bell
Imperial College London and NIHR CLAHRC for Northwest London
Roles: Professor of acute medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anjali Balasanthiran
NIHR CLAHRC for North West London and Westminster Hospital, London
Roles: Clinical research fellow & specialist registrar in diabetes & endocrinology, NIHR CLAHRC for North West London and Westminster Hospital, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.balasanthiran@imperial.ac.uk
Ben Zalin
Lister Hospital, Stevenage
Roles: Consultant in acute medicine, diabetes & endocrinology, Lister Hospital, Stevenage
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma H Baker
St George's Hospital, University of London
Roles: Professor of clinical pharmacology, St George's Hospital, University of London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Shotliff
Chelsea and Westminster Hospital, and honorary senior lecturer, lmperial college, London
Roles: Consultant physician, Chelsea and Westminster Hospital, and honorary senior lecturer, lmperial college, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading
Key Words
  • acute
  • critical care
  • chronic obstructive pulmonary disease
  • myocardial infarction
  • stress hyperglycaemia
  • stroke

Key points

  • Hyperglycaemia is common in the acute care setting, reflecting high prevalence of known or undiagnosed diabetes mellitus (DM) and the physiological effects of acute illness, causing ‘stress hyperglycaemia’

  • There is a continuous association between increasing blood glucose concentrations and worsening clinical outcomes in diverse acute illnesses although causality has not been proven

  • UK guidelines currently recommend blood glucose control in patients admitted with acute coronary syndrome or stroke

  • Patients with acute hyperglycaemia without a prior diagnosis of DM should have HbA1c measured both prior to discharge to determine diagnosis or risk of diabetes and at subsequent follow-up

Hyperglycaemia is common in the acute care setting. In a study of 2,030 adults admitted acutely to hospital, 32% of whom had no prior history of diabetes mellitus (DM), 38% had a fasting blood glucose above 7.0 mmol/l or a random glucose above 11.1 mmol/l.1 Patients with acute hyperglycaemia with no prior diagnosis of diabetes may either have stress hyperglycaemia precipitated by the physiological stress of acute illness or undiagnosed DM. This article provides an overview of the mechanisms, impact and diagnosis of acute hyperglycaemia and outlines recommendations for treatment and follow-up.

Pathophysiology

Mechanisms underlying stress hyperglycaemia include increased release of counter-regulatory hormones and pro-inflammatory cytokines, leading to a rise in insulin resistance and gluconeogenesis. Specific treatments such as glucocorticoids or enteral nutrition, as well as underlying poor pancreatic reserve or insulin resistance, increase the risk of stress hyperglycaemia. A vicious cycle then develops, with hyperglycaemia exacerbating inflammation and oxidative stress which drive worsening hyperglycaemia.2

Impact of acute hyperglycaemia

Acute hyperglycaemia may be an immediate life-threatening emergency due to decompensated or undiagnosed diabetes or a stress response to acute illness (stress hyperglycaemia). Stress hyperglycaemia is also associated with poor outcomes. Patients with hyperglycaemia may be asymptomatic or experience classic symptoms of polyuria, polydipsia and lethargy. Where hyperglycaemia is prolonged, patients may also report recurrent infections, weight loss and blurred vision.

It is crucial to identify hyperglycaemic emergencies such as diabetic ketoacidosis (DKA) and hyperglycaemic hyperosmolar syndrome (HHS) and treat rapidly according to national guidelines. The management of stress hyperglycaemia is less clearly defined and remains the subject of research.

Hyperglycaemic emergencies

Diabetic ketoacidosis

DKA is a complex disordered metabolic state characterised by hyperglycaemia, acidosis and ketonaemia,3 most commonly occurring in patients with new or known type 1 DM due to insulin deficiency or inadequate insulin replacement. Although most often seen in younger people, DKA can occur in elderly patients with long-standing type 1 diabetes. It can also affect patients with type 2 diabetes with relative insulin deficiency (ketosis-prone type 2 diabetes) in combination with severe illness. Clinical features include polyuria, polydipsia, hyperventilation and abdominal pain. Recommended management includes urgent replacement of insulin and fluids, guided by venous (rather than arterial) bicarbonate and pH, with blood ketone testing (using bedside meters).3

Hyperglycaemic hyperosmolar syndrome

HHS typically presents in older patients with type 2 diabetes and has a high mortality. It is characterised by hyperosmolality and dehydration without significant ketoacidosis. Other common clinical features include lethargy and neurological deficit. Management priorities include rehydration, thromboprophylaxis and treatment of any precipitating cause (often infection).

Stress hyperglycaemia

Elevated blood glucose during acute illness is associated with poor outcomes from diverse conditions including myocardial infarction (MI),4,5 stroke6 and respiratory infection.7,8 The relationship between blood glucose and poor outcomes is continuous, so it is difficult to identify a cut-off value above which blood glucose levels are considered abnormal. However, a reasonable definition for stress hyperglycaemia is random blood glucose above 7.0 mmol/l. Acute hyperglycaemia has a greater adverse impact on outcomes in patients without prior DM than in those with diabetes.1,5 At present it is not clear whether hyperglycaemia directly causes poor outcomes or is simply a marker of acute illness severity. Potential adverse effects of hyperglycaemia include increased oxidative stress, impaired endothelial function and activation of the coagulation pathway.

Hyperglycaemia in acute coronary syndrome

In all patients with MI, admission glucose is a strong predictor of increased mortality and in-hospital complications. A review of 15 studies found that the relationship between hyperglycaemia and poor outcomes was particularly strong for patients without prior diabetes.5 In non-diabetic patients, risk of death post-MI was 3.9 times greater in those with admission blood glucose 6.1–8.0 mmol/l, and risk of heart failure or cardiogenic shock three-fold higher in those with admission glucose 8–10 mmol/l than in those with lower admission glucose levels.5 Similarly, persistently elevated glucose levels during admission are associated with increased in-hospital mortality.9

Despite a clear association between hyperglycaemia and poor outcomes, studies of intensive glycaemic control in acute MI (including the Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI) and the Hyperglycaemia: Intensive Insulin Infusion in Infarction (HI-5) studies) have failed to identify an optimal treatment strategy. Factors that may account for conflicting trial evidence include inadequate patient recruitment and glucose control. In this context, the National Institute for Clinical Excellence recommends initiating treatment with a dose-adjusted insulin infusion in patients admitted to hospital with ACS when blood glucose is above 11.0 mmol/l.

A significant proportion of individuals with hyperglycaemia during ACS will have undiagnosed diabetes or glucose intolerance. All patients with hyperglycaemia without prior diagnosis of diabetes should therefore be offered:9

  • glycosylated haemoglobin (HbA1c) test before discharge

  • fasting glucose test no earlier than four days after onset of ACS

  • lifestyle advice

  • counselling regarding symptoms of hyperglycaemia

  • annual general practitioner monitoring of HbA1c and fasting glucose levels.

Hyperglycaemia in stroke

Hyperglycaemia is a common finding in acute ischaemic stroke – reported in 32% of patients without prior diabetes.10 A systematic review concluded that high glucose levels predict increased in-hospital mortality and poor functional recovery in stroke survivors.11 Hyperglycaemia may exacerbate brain injury and induce cell lysis in metabolically-challenged tissue through a variety of mechanisms, including:

  • anaerobic metabolism

  • free radical generation, and

  • increased blood-brain-barrier permeability.12

To date, only one underpowered clinical trial has investigated the effect of glycaemic control on stroke outcome, finding no clinical benefit.13 Despite this, and perhaps in view of the available theoretical evidence,12 various guidelines advocate the treatment of hyperglycaemia in this population (Table 1).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Summary of international recommendations for treatment of hyperglycaemia in acute stroke.

Hyperglycaemia in respiratory infection

Acute hyperglycaemia is particularly common in patients with exacerbations of chronic obstructive pulmonary disease (COPD) due to physiological stress, underlying impaired glucose intolerance and treatment with oral glucocorticoids. In two separate studies, 50% of patients hospitalised with acute COPD exacerbations had random blood glucose of 7 mmol/l or above. Each 1 mmol/l increase in blood glucose increased absolute risk of death or prolonged hospital stay by 15%.8 Hyperglycaemia also predicts failure of non-invasive ventilation after initial success.15 Prospective studies are currently underway to determine whether blood glucose control can improve COPD exacerbation outcomes.

Hyperglycaemia in diabetes mellitus

Prior diagnosis of diabetes

Patients with diabetes accounted for 9.7% of all inpatients in one UK hospital. It is well recognised that the stress of acute illness may exacerbate hyperglycaemia in this population. Acute adjustments in therapy may be required to control blood glucose. Any adjustments should be monitored following resolution of the acute illness to avoid subsequent overtreatment.

Undiagnosed diabetes mellitus

It is estimated that about half a million people in the UK have undiagnosed diabetes. Hyperglycaemia in the acute setting presents an opportunity to identify these individuals and offer appropriate treatment to delay or prevent the onset of diabetic complications. Given that diabetes is a risk factor for macrovascular disease, acute admissions with stroke, transient ischaemic attack, ACS or peripheral vascular disease should prompt investigation. Other populations at risk of diabetes include those who are obese or taking oral corticosteroids. Recent US guidelines recommend that all patients should undergo laboratory glucose testing on admission.17

Diagnosis of diabetes mellitus in the acute care setting

Some measurements taken in acute care and their utility are described in Tables 2 and 3. Stress hyperglycaemia is common, so fasting and random blood glucose measurements in the first few days of acute illness may not be discriminatory in the absence of symptoms. An elevated HbA1c will indicate chronic hyperglycaemia preceding the acute illness, but a ‘normal’ HbA1c does not exclude DM. All patients without diabetes found to have hyperglycaemia in the acute setting should be reviewed on recovery to identify underlying glucose tolerance and determine whether any treatment is necessary (Table 4).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2.

Investigations commonly used to identify hyperglycaemia/new-onset diabetes mellitus in the acute setting.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3.

Interpretation of glycosylated haemoglobin (HbA1c) values.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 4.

Recommended follow-up for patients with hyperglycaemia in the acute setting.

Conclusions

Hyperglycaemia in the acute setting is common and frequently overlooked. In all contexts, acute hyperglycaemia is associated with poor clinical outcomes. Pragmatic guidelines for the treatment of acute hyperglycaemia exist, but further research and improved clinical awareness are required to reduce adverse outcomes and increase the pick-up of undiagnosed diabetes in the acute setting.

  • © 2012 Royal College of Physicians

References

  1. ↵
    1. Umpierrez GE,
    2. Isaacs SD,
    3. Bazargan N,
    4. et al
    . Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978–82
    OpenUrlCrossRefPubMed
  2. ↵
    1. Dungan KM,
    2. Braithwaite SS,
    3. Preiser JC
    . Stress hyperglycaemia. Lancet 2009;373:1798–807doi:10.1016/S0140-6736(09)60553-5
    OpenUrlCrossRefPubMed
  3. ↵
    1. Diabetes UK
    (March 2010) The management of diabetic ketoacidosis in adults, Joint British Diabetes Societies Inpatient Care Group.
  4. ↵
    1. Deedwania P,
    2. Kosiborod M,
    3. Barrett E,
    4. et al
    . Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. AHA Scientific Statement. Circulation 2008;117:1610–9doi:10.1161/CIRCULATIONAHA.107.188629
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Capes SE,
    2. Hunt D,
    3. Malmberg K,
    4. Gerstein HC
    . Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773–8doi:10.1016/S0140-6736(99)08415-9
    OpenUrlCrossRefPubMed
  6. ↵
    1. Samiullah S,
    2. Qasim R,
    3. Imran S,
    4. Mukhtair J
    . Frequency of stress hyperglycaemia and its influence on the outcome of patients with spontaneous intracerebral haemorrhage. J Pak Med Assoc 2010;60:660–3
    OpenUrlPubMed
  7. ↵
    1. McAlister FA,
    2. Majumdar SR,
    3. Blitz S,
    4. et al
    . The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community acquired-pneumonia. Diabetes Care 2005;28:810–5doi:10.2337/diacare.28.4.810
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Baker EH,
    2. Janaway CH,
    3. Phillips BJ,
    4. et al
    . Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006;61:284–9doi:10.1136/thx.2005.051029
    OpenUrlAbstract/FREE Full Text
  9. ↵
    National Institute for Health and Clinical Excellence. Hyperglycaemia in acute coronary syndromes October 2011NICE clinical guideline CG130
  10. ↵
    1. Allport L,
    2. Baird T,
    3. Butcher K,
    4. et al
    . Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care 2006;29:1839–44doi:10.2337/dc06-0204
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Capes SE,
    2. Hunt D,
    3. Malmberg K,
    4. Patna P,
    5. Gerstein HC
    . Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426–32doi:10.1161/hs1001.096194
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Lindsberg PJ,
    2. Roine RO
    . Hyperglycemia in acute stroke. Stroke 2004;35:363–4doi:10.1161/01.STR.0000115297.92132.84
    OpenUrlFREE Full Text
  13. ↵
    1. Gray CS,
    2. Hildreth AJ,
    3. Sandercock PA,
    4. et al
    . Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007;6:397–406doi:10.1016/S1474-4422(07)70080-7
    OpenUrlCrossRefPubMed
  14. (2008) National Institute for Health and Clinical Excellence. Diagnosis and initial management of acute stroke and transient ischaemic attack (TIA) NICE clinical guideline CG68, July.
  15. ↵
    1. Moretti M,
    2. Cilione C,
    3. Tampieri,
    4. et al
    . Incidence and causes of non-invasive mechanical ventilation failure after initial success. Thorax 2000;55:819–25doi:10.1136/thorax.55.10.819
    OpenUrlAbstract/FREE Full Text
    1. Sampson MJ,
    2. Crowle T,
    3. Dhatariya K,
    4. et al
    . Trends in bed occupancy for inpatients with diabetes before and after the introduction of a diabetes inpatient specialist nurse service. Diabet Med 2006;23:1008–15doi:10.1111/j.1464-5491.2006.01928.x
    OpenUrlCrossRefPubMed
  16. ↵
    1. Umpierrez GE,
    2. Hellman R,
    3. Korytkowski MT,
    4. et al
    . Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2012;97:16–38doi:10.1210/jc.2011-2098
    OpenUrlCrossRefPubMed
  17. (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO/IDF consultation, January.
    1. Diabetes UK
    . New Diagnostic Criteria for Diabetes and Practical Guidance:Jan 2011http://www.diabetes.org.uk/About_us/Our_Views/Care_recommendations/New_diagnostic_criteria_for_diabetes_.
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Hyperglycaemia in the acute care setting
Anjali Balasanthiran, Ben Zalin, Emma H Baker, Kevin Shotliff
Clinical Medicine Jun 2012, 12 (3) 272-275; DOI: 10.7861/clinmedicine.12-3-272

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Hyperglycaemia in the acute care setting
Anjali Balasanthiran, Ben Zalin, Emma H Baker, Kevin Shotliff
Clinical Medicine Jun 2012, 12 (3) 272-275; DOI: 10.7861/clinmedicine.12-3-272
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Pathophysiology
    • Impact of acute hyperglycaemia
    • Hyperglycaemic emergencies
    • Stress hyperglycaemia
    • Hyperglycaemia in acute coronary syndrome
    • Hyperglycaemia in stroke
    • Hyperglycaemia in respiratory infection
    • Hyperglycaemia in diabetes mellitus
    • Conclusions
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

CME SECTION

  • Recognising acute kidney injury
  • Community acquired pneumonia: assessment and treatment
  • Poisoning and self-harm
Show more CME SECTION

Acute Medicine

  • Community acquired pneumonia: assessment and treatment
  • Poisoning and self-harm
Show more Acute Medicine

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians